It has been reported that MELK is frequently and highly upregulated in various types of human cancer, both solid tumors and hematological cancers, and that elevated MELK expression is correlated with poor prognosis of cancer patients [5]. This evidence concerns the gene MELK and hematopoietic and lymphoid cell neoplasm.